SCHEMBL20168656

SCHEMBL20168656

O=C(O)CC(C(=O)O)(C(=O)O)C1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
ALDH1A1 P00352 4/20 0.37
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
EPHX2 P34913 1/20 0.34
LMNA P02545 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
GRM2 Q14416 1/20 0.33
GRM3 Q14832 1/20 0.33
EPHX1 P07099 1/20 0.33
HMGCR P04035 1/20 0.32
CHRM1 P11229 1/20 0.32
TBXA2R P21731 1/20 0.32
ADRA1A P35348 1/20 0.32
ACLY P53396 2/20 0.31
KIF11 P52732 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2525779 0.83 KEAP1 (0.31) KEAP1NFE2L2
SCHEMBL10358243 0.80 KEAP1 (0.36) KEAP1NFE2L2ALDH1A1CYP2D6TSHR
SCHEMBL31352036 0.79 ALDH1A1 (0.36) KEAP1NFE2L2ALDH1A1CYP2D6TSHR
SCHEMBL2579739 0.79 ALDH1A1 (0.36) KEAP1NFE2L2ALDH1A1CYP2D6TSHR
SCHEMBL11365788 0.78 CYP2C19 (0.38) ALDH1A1CYP2D6TSHRCYP2C19HIF1A
SCHEMBL8131339 0.77 KEAP1 (0.37) KEAP1NFE2L2ALDH1A1CYP2D6TSHR
SCHEMBL9129355 0.77 ALDH1A1 (0.35) KEAP1NFE2L2ALDH1A1CYP2D6TSHR
SCHEMBL8735978 0.77 KEAP1 (0.37) KEAP1NFE2L2ALDH1A1CYP2D6CYP2C19
SCHEMBL29142969 0.77 KEAP1 (0.37) KEAP1NFE2L2ALDH1A1CYP2D6TSHR
SCHEMBL28107685 0.77 CYP2D6 (0.41) KEAP1NFE2L2ALDH1A1CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110472-A1 BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND HER2, AND METHODS OF USE THEREOF Regeneron Pharmaceuticals, Inc. (US) 2023-01-04 EP disclosed
EP-3541842-A1 ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF Regeneron Pharmaceuticals, Inc. (US) 2019-09-25 EP disclosed
WO-2018093866-A1 ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2018-05-24 WO disclosed